Navigation Links
Kiadis Pharma Announces Promising Phase II Clinical Trial Results for Reviroc
Date:8/30/2007

GRONINGEN, Netherlands, Aug. 31 /PRNewswire-FirstCall/ -- Oncology focused pharmaceutical development company Kiadis Pharma announced today that it has successfully completed a Phase II clinical trial evaluating its product Reviroc(TM). Reviroc is used to eliminate cancer cells from an autologous graft in bone marrow transplantations for end-stage blood cancer patients. Data from the clinical study revealed improved overall survival of Reviroc-treated patients. The successful completion of the clinical trial allows Kiadis Pharma to prepare for a Phase III clinical study.

Manja Bouman, CEO, Kiadis Pharma, comments: "We are obviously very pleased with the completion of this Phase II trial of Reviroc. It brings treatment with our product a step closer to patients with end stage blood cancer. Reviroc shares its development platform with two other Kiadis Pharma products: ATIR and Rhitol. The results of this trial therefore mark an important milestone in the development of our entire clinical product pipeline."

In the non-randomized open label study 25 patients, each of whom had reached end stage Non-Hodgkin's lymphoma, were treated in multiple centers in Canada. The objective of the study was to determine the safety of the Reviroc treatment and its ability to eliminate cancer cells from a contaminated graft. Reviroc-treated grafts all showed excellent engraftment, indicating that Reviroc does not negatively impact the graft itself.

The Reviroc clinical trial data was evaluated against a historical patient control group from the Center for International Blood and Marrow Transplant Research (CIBMTR). The results for Reviroc-treated patients were compared with results from the CIBMTR database for patients who had received an autologous transplant without Reviroc. The outcome of this comparison shows that the Reviroc-treated patient group had an 80% chance of survival at 3 years post transplantation, while the CIBMTR control group had a 55% chance of
'/>"/>

SOURCE Kiadis Pharma
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... SAN DIEGO, Calif., Dec. 4 Suneva Medical, a ... of Philip Ranker as Vice President and Chief Financial ... all Suneva Medical,s general and administrative functions including finance, ... will also serve on the Company,s senior management team. ...
(Date:12/4/2009)... OrthoAccel Technologies, Inc., developers of the AcceleDent ... enhance orthodontics, announced the availability of a new ... , a leader in professional education for many ... focuses on patient views about orthodontic treatment, a ...
(Date:12/4/2009)... N.Y., Dec. 4 Bayer Diabetes Care today announced the ... Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the ... the country. The grand prize is an in-person meeting today ... 1 diabetes like Nick, are: Caleb, age 6, from Danbury, ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Clearly Contacts Named to BC Business Magazine Top 100 Public Companies List 50362 1Clearly Contacts Named to BC Business Magazine Top 100 Public Companies List 50362 2Teacher and Profession Leader William A Grana MD MPH Inducted into Sports Medicine Hall of Fame 50357 1Teacher and Profession Leader William A Grana MD MPH Inducted into Sports Medicine Hall of Fame 50357 2Teacher and Profession Leader William A Grana MD MPH Inducted into Sports Medicine Hall of Fame 50357 3Chiltern Opens Office in Budapest Hungary 50352 1Chiltern Opens Office in Budapest Hungary 50352 2
... Health South Florida Reports on 11 Patients at SAWCPRINCETON, N.J., ... Derma Sciences (OTC Bulletin Board: DSCI), a ... the annual Symposium on the Advances in Wound Care (SAWC) ... at Baptist Health South Florida, revealed details of a recently ...
... The recent announcement of the REDUCE trial results at ... to the prostate cancer community as dutasteride (Avodart), a drug ... by 23 percent the risk of prostate cancer in men ... looks forward to this becoming an additional tool in the ...
Other Medicine Technology:Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 2Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 3Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer 2
(Date:12/6/2009)... Treatment site www.sleeping-with-a-sleeping-disorder.com is asking people ... natural sleep aids from around the world to ... cause. The submissions will be compiled in an ... YOU, to be sold from the website in ... of the proceeds ,from sales of the E-book ...
(Date:12/5/2009)... 5 ,, What: Cuts for a ... in the fight against cancer and other terminal illnesses affecting ... donated to St. Jude Children,s Research Hospital. Guests will enjoy ... delectable and savory Vietnamese restaurant in Falls Church for all ...
(Date:12/5/2009)... being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- ... without ever tying the knot, since research has shown that ... um, isn,t there something wrong with those who go it ... looking at psychological measures shows that never-married people aged 40 ...
(Date:12/4/2009)... Calif., Dec. 4 Varian Medical Systems (NYSE: ... set the regular 2010 Annual Meeting of Stockholders for February ... The meeting will be held at the Crowne Plaza Cabana ... p.m. PT. ,, The meeting will be webcast by Thomson ...
(Date:12/4/2009)... Homes and Services for the Aging (AAHSA) applauds the Senate ... (CLASS) provisions remain in the final health reform legislation . ... people with disabilities and their caregivers. ,, We urge ... will make it affordable to care for families and caregivers. ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2
... had similar survival rates to that from younger donors ... the age of 75 should be allowed to donate corneas ... The researchers found that tissue from donors aged 66 to ... corneas from donors aged 12 to 65. , The research, ...
... fit into her prom dress, but you gain five pounds if ... for Weight Watchers and that gym membership, though, you may want ... save yourself a few hundred dollars. , A womans waistline may ... than it does with the genes of her parents, according to ...
... 1, 2008) - A new study has found that ... kidneys did not prevent renal injury during percutaneous coronary ... function. In addition, it made no difference in the ... stay, according to the Contrast Media and Nephrotoxicity Following ...
... trails for ... Revolutionary 5-mile Run, VALLEY FORGE, Pa., April 1, 2008 ... Denny Chipollini,considers gifts. Chipollini has experienced a series of life-altering,events, ... accident and the,contraction of Hepatitis C through a blood transfusion., ...
... future of loved ones with special ... ... Insurance Company (MassMutual) today made available on its Web site a,free template ... or supplementing life care plans for family members with a,disability or other ...
... SCOTTSDALE, Ariz. and ANN ARBOR, Mich., April 1, ... (IHPM) announces the,industry,s first Behavioral Health Workplace Center ... in scalable behavior change,interventions with demonstrable outcomes. Employers ... research shows that:, -- Behavioral health ...
Other Medicine News:Health News:Study Finds Older Corneas Suitable for Transplantation 2Health News:The lean gene 2Health News:Iso-osmolar X-ray dye falters in PCI study 2Health News:Iso-osmolar X-ray dye falters in PCI study 3Health News:For Inspiring Amputee It's No Excuses, No Limits 2Health News:MassMutual Offers Free 'Letter of Intent' Template to People with Disabilities and Their Families, Caregivers 2Health News:MassMutual Offers Free 'Letter of Intent' Template to People with Disabilities and Their Families, Caregivers 3Health News:IHPM and HealthMedia Announce Industry's First Behavioral Health Workplace Center for Employers 2Health News:IHPM and HealthMedia Announce Industry's First Behavioral Health Workplace Center for Employers 3
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
... The NIDEK MK-2000 ... performance in a wide ... MK-2000 utilizes single-use, ultra-sharp ... Blades are supplied sterile ...
The iQ200 Automated Urinalysis System (iQ System) is a user-friendly, bench top, fully automated system that performs complete urinalyses on unspun specimens; simply load, press START and walk away....
Medicine Products: